TY - JOUR
T1 - SLE initially presenting with neuropsychiatric manifestations and seizure, case report
AU - Khormi, Abdulrahman Ali M.
AU - Hijazi, Faisal Taher
N1 - Publisher Copyright:
© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
PY - 2023/6
Y1 - 2023/6
N2 - Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder exhibiting variable disease courses and multiple clinical manifestations. SLE's aetiology remains unclear; however, different environmental (e.g., ultraviolet light, infections, drugs, etc.), genetic, and hormonal factors are potentially involved. A positive family history and history of having other autoimmune illnesses are considered high-risk factors for SLE; nevertheless, most SLE cases are scattered. The 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE include at least one positive antinuclear antibody test as a mandatory entry criterion, followed by additive weighted standards grouped in seven clinical (constitutional, haematological, neuropsychiatric, serosal, musculoskeletal, renal, and mucocutaneous) and three immunological (antiphospholipid antibodies, complement proteins, and SLE-specific antibodies) domains weighted from 2 to 10, with patients accumulating ≥10 points being diagnosed with SLE. Herein, we report a case of neuropsychiatric lupus, a rare and severe form of SLE.
AB - Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder exhibiting variable disease courses and multiple clinical manifestations. SLE's aetiology remains unclear; however, different environmental (e.g., ultraviolet light, infections, drugs, etc.), genetic, and hormonal factors are potentially involved. A positive family history and history of having other autoimmune illnesses are considered high-risk factors for SLE; nevertheless, most SLE cases are scattered. The 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE include at least one positive antinuclear antibody test as a mandatory entry criterion, followed by additive weighted standards grouped in seven clinical (constitutional, haematological, neuropsychiatric, serosal, musculoskeletal, renal, and mucocutaneous) and three immunological (antiphospholipid antibodies, complement proteins, and SLE-specific antibodies) domains weighted from 2 to 10, with patients accumulating ≥10 points being diagnosed with SLE. Herein, we report a case of neuropsychiatric lupus, a rare and severe form of SLE.
KW - autoimmunity
KW - blood
KW - diseases
KW - systemic lupus erythematosus
KW - tissues
UR - http://www.scopus.com/inward/record.url?scp=85163650852&partnerID=8YFLogxK
U2 - 10.1002/iid3.918
DO - 10.1002/iid3.918
M3 - Article
C2 - 37382262
AN - SCOPUS:85163650852
SN - 2050-4527
VL - 11
JO - Immunity, inflammation and disease
JF - Immunity, inflammation and disease
IS - 6
M1 - e918
ER -